These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma. Serup J; Staun-Olsen P Allergy; 1986 Aug; 41(6):452-6. PubMed ID: 3491549 [TBL] [Abstract][Full Text] [Related]
5. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Marzano AV; Menni S; Parodi A; Borghi A; Fuligni A; Fabbri P; Caputo R Eur J Dermatol; 2003; 13(2):171-6. PubMed ID: 12695134 [TBL] [Abstract][Full Text] [Related]
9. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Falanga V; Medsger TA; Reichlin M Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090 [TBL] [Abstract][Full Text] [Related]
10. Localized and systemic scleroderma. Hawk A; English JC Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134 [TBL] [Abstract][Full Text] [Related]
11. Localized scleroderma: a clinical study at a single center in Korea. Noh JW; Kim J; Kim JW Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against antigens related to scleroderma in a cohort of patients with morphea. Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114 [TBL] [Abstract][Full Text] [Related]
13. Scleroderma in children and adolescents. Murray KJ; Laxer RM Rheum Dis Clin North Am; 2002 Aug; 28(3):603-24. PubMed ID: 12380372 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182 [TBL] [Abstract][Full Text] [Related]
15. [Scleroderma in children: a retrospective study of 70 cases]. Bodemer C; Belon M; Hamel-Teillac D; Amoric JC; Fraitag S; Prieur AM; De Prost Y Ann Dermatol Venereol; 1999 Oct; 126(10):691-4. PubMed ID: 10604006 [TBL] [Abstract][Full Text] [Related]
16. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Hayakawa I; Hasegawa M; Takehara K; Sato S Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory arthritis in pediatric patients with morphea. Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035 [TBL] [Abstract][Full Text] [Related]
19. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534 [TBL] [Abstract][Full Text] [Related]
20. Coexistence of morphea and systemic sclerosis. Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]